New Ultra-Sensitive Assays Aim to Improve Early Detection of Alzheimer’s and Parkinson’s Disease
Three new immunoassays targeting key neurodegeneration biomarkers require just 1 µL of plasma and run on standard laboratory instruments.
Read More
Search Results for: genetic testing
FDA Approves MyChoice CDx as Companion Diagnostic for Zejula in Ovarian Cancer
The approval makes MyChoice CDx the sole FDA-approved test in the US to identify HRD-positive patients eligible for niraparib maintenance therapy.
Read More
Blood Test May Help Guide Breast Cancer Treatment Decisions in Women 70 and Older
Researchers found that circulating tumor DNA testing could identify which older patients with estrogen receptor–positive breast cancer are less likely to respond to hormone therapy alone.
Read More
Researchers Develop First DNA Aptamers That Bind Alzheimer’s Blood Biomarker Neurofilament Light Chain
The newly identified aptamers match antibody-level binding strength and could support the development of lower-cost, point-of-care blood tests for neurodegeneration.
Read More
ADDF Launches Third Phase of Diagnostics Accelerator with $50 Million to Advance Alzheimer’s Blood Tests and AI Biomarkers
The new funding brings the initiative’s total to $150 million and will focus on tau pathology, multi-marker panels, and AI-driven diagnostics.
Read More